David J. Diemert

Infectious Disease
50 Irving St NW
Washington, DC 20422

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 62 publications

Influenza A and B Viral Shedding in Adults Immunized with Live Attenuated Influenza Vaccine.

Influenza A and B Viral Shedding in Adults Immunized with Live Attenuated Influenza Vaccine.

Journal: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
Published: November 24, 2025

The neutralizing antibody titer correlate of COVID-19 risk in the COVID-19 variant immunologic landscape (COVAIL) trial was not modified by SARS-CoV-2 amino acid sequence distances.

The neutralizing antibody titer correlate of COVID-19 risk in the COVID-19 variant immunologic landscape (COVAIL) trial was not modified by SARS-CoV-2 amino acid sequence distances.

Journal: Vaccine
Published: October 31, 2025

Na-GST-1 adsorbed on Alhydrogel co-administered with different Toll-like receptor agonists in hookworm-naive adults using a controlled human infection model in the USA: a phase 2, double-blind, randomised controlled trial.

Na-GST-1 adsorbed on Alhydrogel co-administered with different Toll-like receptor agonists in hookworm-naive adults using a controlled human infection model in the USA: a phase 2, double-blind, randomised controlled trial.

Journal: The Lancet. Infectious diseases
Published: October 29, 2025

Evaluation of the safety and immunogenicity of two fractional intradermal regimens of MVA-BN compared to standard dose vaccination.

Evaluation of the safety and immunogenicity of two fractional intradermal regimens of MVA-BN compared to standard dose vaccination.

Journal: Vaccine
Published: May 27, 2025

Precise targeting of HIV broadly neutralizing antibody precursors in humans.

Precise targeting of HIV broadly neutralizing antibody precursors in humans.

Journal: Science (New York, N.Y.)
Published: May 15, 2025

Vaccination with mRNA-encoded nanoparticles drives early maturation of HIV bnAb precursors in humans.

Vaccination with mRNA-encoded nanoparticles drives early maturation of HIV bnAb precursors in humans.

Journal: Science (New York, N.Y.)
Published: May 15, 2025

Manufacture of Necator americanus as an infectious challenge agent: Accelerating human hookworm vaccine development.

Manufacture of Necator americanus as an infectious challenge agent: Accelerating human hookworm vaccine development.

Journal: Microbial pathogenesis
Published: March 04, 2025

Effect of Omicron BA.1-based compared to prototype booster mRNA vaccination on incidence of COVID-19 in the COVAIL trial.

Effect of Omicron BA.1-based compared to prototype booster mRNA vaccination on incidence of COVID-19 in the COVAIL trial.

Journal: Vaccine
Published: February 17, 2025

Randomized, observer-blind, controlled Phase 1 study of the safety and immunogenicity of the Na-GST-1/Alhydrogel hookworm vaccine with or without a CpG ODN adjuvant in hookworm-naïve adults.

Randomized, observer-blind, controlled Phase 1 study of the safety and immunogenicity of the Na-GST-1/Alhydrogel hookworm vaccine with or without a CpG ODN adjuvant in hookworm-naïve adults.

Journal: PLoS neglected tropical diseases
Published: October 08, 2024

Neutralizing antibody immune correlates in COVAIL trial recipients of an mRNA second COVID-19 vaccine boost.

Neutralizing antibody immune correlates in COVAIL trial recipients of an mRNA second COVID-19 vaccine boost.

Journal: Nature communications
Published: July 19, 2024

Neutralizing Antibody Immune Correlates for a Recombinant Protein Vaccine in the COVAIL Trial.

Neutralizing Antibody Immune Correlates for a Recombinant Protein Vaccine in the COVAIL Trial.

Journal: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
Published: May 06, 2024

Safety and immunogenicity of the co-administered Na-APR-1 and Na-GST-1 hookworm vaccines in school-aged children in Gabon: a randomised, controlled, observer-blind, phase 1, dose-escalation trial.

Safety and immunogenicity of the co-administered Na-APR-1 and Na-GST-1 hookworm vaccines in school-aged children in Gabon: a randomised, controlled, observer-blind, phase 1, dose-escalation trial.

Journal: The Lancet. Infectious diseases
Published: January 01, 2024
Showing 1-12 of 62

Last Updated: 09/26/2026